HSBC Holdings’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-43,100
Closed -$4.28M 3302
2019
Q3
$4.28M Sell
43,100
-34,000
-44% -$3.23M 0.01% 1254
2019
Q2
$7.13M Sell
77,100
-43,500
-36% -$4.13M 0.01% 996
2019
Q1
$11.4M Sell
120,600
-85,900
-42% -$7.51M 0.02% 741
2018
Q4
$13.2M Buy
206,500
+57,000
+38% +$4.21M 0.02% 672
2018
Q3
$13.4M Buy
149,500
+22,800
+18% +$2.01M 0.02% 737
2018
Q2
$10.1M Buy
126,700
+15,200
+14% +$1.26M 0.02% 806
2018
Q1
$9.93M Buy
+111,500
New +$10.7M 0.01% 823
2017
Q4
Sell
-181,000
Closed -$26.4M 2514
2017
Q3
$26.4M Buy
181,000
+37,200
+26% +$5.07M 0.04% 440
2017
Q2
$18.7M Sell
143,800
-37,100
-21% -$4.55M 0.03% 533
2017
Q1
$22.5M Buy
180,900
+85,100
+89% +$10.2M 0.05% 439
2016
Q4
$11.1M Buy
95,800
+19,500
+26% +$2.17M 0.03% 685
2016
Q3
$7.98M Buy
76,300
+2,200
+3% +$238K 0.02% 754
2016
Q2
$7.31M Buy
74,100
+72,400
+4,259% +$7.49M 0.02% 775
2016
Q1
$170K Sell
1,700
-75,200
-98% -$7.74M ﹤0.01% 1961
2015
Q4
$9.21M Buy
76,900
+72,900
+1,823% +$8.43M 0.02% 721
2015
Q3
$433K Sell
4,000
-44,238
-92% -$5.49M ﹤0.01% 1457
2015
Q2
$5.58M Sell
48,238
-10,162
-17% -$1.16M 0.01% 795
2015
Q1
$6.73M Buy
58,400
+30,600
+110% +$3.66M 0.01% 809
2014
Q4
$3.11M Hold
27,800
0.01% 1043
2014
Q3
$2.63M Buy
+27,800
New +$2.51M 0.01% 1077
2014
Q1
Sell
-41,000
Closed -$3.46M 1854
2013
Q4
$3.46M Buy
+41,000
New +$3.24M 0.01% 973
2013
Q3
Sell
-106,000
Closed -$6.2M 1869
2013
Q2
$6.2M Buy
+106,000
New +$6.38M 0.02% 635

Other funds holding CELG

HSBC Holdings's CELG Position: Q4 2019 in Review

HSBC Holdings sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 666,283 shares — an estimated $66.2M sold.

HSBC Holdings first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $229M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • HSBC Holdings reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • HSBC Holdings sold 666,283 Celgene Corp shares in Q4 2019, an estimated $66.2M.
  • HSBC Holdings first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • HSBC Holdings's Celgene Corp position peaked at $229M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on HSBC Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.